Diaz-Padilla I - Search Results

1

Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.

Diaz-Padilla I, Romero N, Amir E, Matias-Guiu X, Vilar E, Muggia F, Garcia-Donas J. Diaz-Padilla I, et al. Crit Rev Oncol Hematol. 2013 Oct;88(1):154-67. doi: 10.1016/j.critrevonc.2013.03.002. Epub 2013 Apr 4. Crit Rev Oncol Hematol. 2013. PMID: 23562498 Review.

2

Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.

Diaz-Padilla I, Amir E, Marsh S, Liu G, Mackay H. Diaz-Padilla I, et al. Gynecol Oncol. 2012 Feb;124(2):354-65. doi: 10.1016/j.ygyno.2011.10.034. Epub 2011 Nov 6. Gynecol Oncol. 2012. PMID: 22063461 Review.

3

Circulating and disseminated tumor cells in ovarian cancer: a systematic review.

Romero-Laorden N, Olmos D, Fehm T, Garcia-Donas J, Diaz-Padilla I. Romero-Laorden N, et al. Gynecol Oncol. 2014 Jun;133(3):632-9. doi: 10.1016/j.ygyno.2014.03.016. Epub 2014 Mar 19. Gynecol Oncol. 2014. PMID: 24657303 Review.

4

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, Seruga B, Tannock IF, Ocana A, Amir E. Vera-Badillo FE, et al. J Natl Cancer Inst. 2014 Jan;106(1):djt319. doi: 10.1093/jnci/djt319. Epub 2013 Nov 22. J Natl Cancer Inst. 2014. PMID: 24273215 Review.

5

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.

Patrono MG, Minig L, Diaz-Padilla I, Romero N, Rodriguez Moreno JF, Garcia-Donas J. Patrono MG, et al. Ecancermedicalscience. 2013 Dec 17;7:379. doi: 10.3332/ecancer.2013.379. Ecancermedicalscience. 2013. PMID: 24386008 Free PMC article. Review.

6

Treatment of metastatic cervical cancer: future directions involving targeted agents.

Diaz-Padilla I, Monk BJ, Mackay HJ, Oaknin A. Diaz-Padilla I, et al. Crit Rev Oncol Hematol. 2013 Mar;85(3):303-14. doi: 10.1016/j.critrevonc.2012.07.006. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22883215 Review.

7

Ovarian low-grade serous carcinoma: a comprehensive update.

Diaz-Padilla I, Malpica AL, Minig L, Chiva LM, Gershenson DM, Gonzalez-Martin A. Diaz-Padilla I, et al. Gynecol Oncol. 2012 Aug;126(2):279-85. doi: 10.1016/j.ygyno.2012.04.029. Epub 2012 Apr 30. Gynecol Oncol. 2012. PMID: 22555104 Review.

8

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.

Abdul Razak AR, Li L, Bryant A, Diaz-Padilla I. Abdul Razak AR, et al. Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD007584. doi: 10.1002/14651858.CD007584.pub2. Cochrane Database Syst Rev. 2011. PMID: 21412906 Free PMC article. Review.

9

Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer.

Diaz-Padilla I, Duran I, Clarke BA, Oza AM. Diaz-Padilla I, et al. Cancer Treat Rev. 2012 Oct;38(6):767-75. doi: 10.1016/j.ctrv.2012.02.001. Epub 2012 Feb 29. Cancer Treat Rev. 2012. PMID: 22381585 Review.

10

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia.

Diaz-Padilla I, Wilson MK, Clarke BA, Hirte HW, Welch SA, Mackay HJ, Biagi JJ, Reedijk M, Weberpals JI, Fleming GF, Wang L, Liu G, Zhou C, Blattler C, Ivy SP, Oza AM. Diaz-Padilla I, et al. Gynecol Oncol. 2015 May;137(2):216-22. doi: 10.1016/j.ygyno.2015.03.005. Epub 2015 Mar 11. Gynecol Oncol. 2015. PMID: 25769658 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page